Methylation of the BRCA1 promoter in peripheral blood DNA is associated with triple-negative and medullary breast cancer

Gene expression profiling predicts clinical outcome of breast cancer

Laura van ‘t Veer, Hongyue Dai, Marc J. van de Vijver et al. · Nature · 2002 · 9.6K citations · Full text

Life Sciences, Molecular Biology, Oncology +16

Promoter Hypermethylation and BRCA1 Inactivation in Sporadic Breast and Ovarian Tumors

Manel Esteller · JNCI Journal of the National Cancer Institute · 2000 · 1.2K citations · Full text

Medicine, Genetics, Oncology +16

The Pathology of Familial Breast Cancer: Predictive Value of Immunohistochemical Markers Estrogen Receptor, Progesterone Receptor, HER-2, and p53 in Patients With Mutations in <i>BRCA1</i> and <i>BRCA2</i>

Sunil R. Lakhani, Marc J. van de Vijver, Jocelyne Jacquemier et al. · Journal of Clinical Oncology · 2002 · 827 citations

Medicine, Oncology, Pathology +17

Pathology of Breast and Ovarian Cancers among <i>BRCA1</i> and <i>BRCA2</i> Mutation Carriers: Results from the Consortium of Investigators of Modifiers of <i>BRCA1</i> / <i>2</i> (CIMBA)

Nasim Mavaddat, Daniel Barrowdale, Irene L. Andrulis et al. · Cancer Epidemiology Biomarkers & Prevention · 2012 · 668 citations · Full text

Medicine, Genetics, Oncology +15

Clinical and Pathologic Characteristics of Patients With <i>BRCA</i>-Positive and <i>BRCA</i>-Negative Breast Cancer

Deann P. Atchley, Constance T. Albarracin, Adriana López et al. · Journal of Clinical Oncology · 2008 · 604 citations · Full text

Medicine, Oncology, Breast Oncology +12